Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Marker Therapeutics Inc have a median target of 15.75, with a high estimate of 19.00 and a low estimate of 12.50. The median estimate represents a 433.59% increase from the last price of 2.95.
High | 543.7% | 19.00 |
Med | 433.6% | 15.75 |
Low | 323.5% | 12.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 24, 2025.
Average growth rate | +21.79% |
Average growth rate | +21.70% |
More ▼
Revenue history & estimates in USD
Average growth rate | -4.97% |
Average growth rate | +228.66% |
More ▼